Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 9 | 2025 | 1797 | 2.680 |
Why?
|
| Gastroesophageal Reflux | 2 | 2023 | 237 | 1.200 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2022 | 302 | 1.040 |
Why?
|
| Emigrants and Immigrants | 3 | 2017 | 157 | 0.840 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2017 | 168 | 0.830 |
Why?
|
| Polysomnography | 1 | 2024 | 239 | 0.770 |
Why?
|
| Citrulline | 1 | 2023 | 45 | 0.750 |
Why?
|
| Cannabinoids | 1 | 2024 | 184 | 0.720 |
Why?
|
| Respiratory Insufficiency | 2 | 2022 | 326 | 0.640 |
Why?
|
| Obesity | 3 | 2024 | 3116 | 0.630 |
Why?
|
| Noninvasive Ventilation | 1 | 2020 | 62 | 0.600 |
Why?
|
| Dermatitis, Atopic | 1 | 2023 | 322 | 0.590 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 325 | 0.530 |
Why?
|
| Sleep | 1 | 2024 | 888 | 0.510 |
Why?
|
| Unsafe Sex | 2 | 2014 | 61 | 0.490 |
Why?
|
| Hospital Mortality | 1 | 2020 | 1038 | 0.460 |
Why?
|
| Risk-Taking | 1 | 2017 | 323 | 0.430 |
Why?
|
| Sexual Behavior | 2 | 2017 | 494 | 0.410 |
Why?
|
| Social Support | 1 | 2017 | 646 | 0.390 |
Why?
|
| Ornithine | 2 | 2023 | 27 | 0.380 |
Why?
|
| Substance-Related Disorders | 3 | 2017 | 1102 | 0.370 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 217 | 0.370 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2025 | 260 | 0.360 |
Why?
|
| Morbidity | 2 | 2023 | 322 | 0.350 |
Why?
|
| Arginine | 2 | 2023 | 264 | 0.340 |
Why?
|
| New Orleans | 4 | 2017 | 19 | 0.280 |
Why?
|
| Comorbidity | 2 | 2021 | 1661 | 0.230 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 5905 | 0.230 |
Why?
|
| Pneumonia | 2 | 2023 | 636 | 0.230 |
Why?
|
| Humans | 18 | 2025 | 145475 | 0.230 |
Why?
|
| Health Surveys | 3 | 2017 | 518 | 0.220 |
Why?
|
| HIV Infections | 2 | 2017 | 3194 | 0.210 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 55 | 0.190 |
Why?
|
| Adult | 8 | 2024 | 40777 | 0.180 |
Why?
|
| Causality | 1 | 2023 | 126 | 0.180 |
Why?
|
| Critical Care Outcomes | 1 | 2020 | 11 | 0.170 |
Why?
|
| Status Asthmaticus | 1 | 2020 | 13 | 0.170 |
Why?
|
| Marijuana Use | 1 | 2024 | 222 | 0.160 |
Why?
|
| Quality of Life | 2 | 2023 | 3204 | 0.160 |
Why?
|
| Dyspnea | 1 | 2022 | 250 | 0.150 |
Why?
|
| Muscarinic Antagonists | 1 | 2019 | 30 | 0.150 |
Why?
|
| Exercise Test | 1 | 2022 | 630 | 0.140 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 390 | 0.130 |
Why?
|
| Cannabis | 1 | 2024 | 509 | 0.130 |
Why?
|
| Middle Aged | 4 | 2024 | 36215 | 0.130 |
Why?
|
| Life Style | 1 | 2019 | 485 | 0.130 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2021 | 339 | 0.130 |
Why?
|
| Cohort Studies | 2 | 2020 | 6013 | 0.120 |
Why?
|
| Male | 7 | 2024 | 72843 | 0.120 |
Why?
|
| Alcoholism | 1 | 2023 | 822 | 0.120 |
Why?
|
| Female | 6 | 2024 | 78845 | 0.110 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 713 | 0.110 |
Why?
|
| Disease Management | 1 | 2019 | 653 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2021 | 780 | 0.110 |
Why?
|
| Phenotype | 1 | 2023 | 3155 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 602 | 0.110 |
Why?
|
| Critical Care | 1 | 2020 | 702 | 0.110 |
Why?
|
| Sepsis | 1 | 2020 | 664 | 0.100 |
Why?
|
| Critical Illness | 1 | 2020 | 900 | 0.100 |
Why?
|
| Weight Loss | 1 | 2019 | 858 | 0.100 |
Why?
|
| Condoms | 1 | 2014 | 102 | 0.100 |
Why?
|
| Volunteers | 1 | 2013 | 39 | 0.090 |
Why?
|
| Disease Progression | 1 | 2020 | 2864 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 2381 | 0.090 |
Why?
|
| Risk Factors | 3 | 2017 | 10885 | 0.090 |
Why?
|
| Behavior, Addictive | 1 | 2013 | 88 | 0.090 |
Why?
|
| Social Identification | 1 | 2013 | 71 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2023 | 17291 | 0.090 |
Why?
|
| Diet | 1 | 2019 | 1277 | 0.090 |
Why?
|
| Sexual Partners | 1 | 2013 | 193 | 0.090 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 176 | 0.090 |
Why?
|
| Community Health Services | 1 | 2013 | 231 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2023 | 8057 | 0.080 |
Why?
|
| Ambulatory Care Facilities | 1 | 2013 | 269 | 0.080 |
Why?
|
| Young Adult | 3 | 2017 | 14219 | 0.080 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 207 | 0.080 |
Why?
|
| Students, Medical | 1 | 2013 | 378 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 1747 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 2953 | 0.060 |
Why?
|
| Adolescent | 2 | 2022 | 22530 | 0.050 |
Why?
|
| Mycobacterium avium Complex | 1 | 2021 | 87 | 0.040 |
Why?
|
| Aged | 1 | 2020 | 26153 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2022 | 283 | 0.040 |
Why?
|
| United States | 1 | 2014 | 16098 | 0.030 |
Why?
|
| Binge Drinking | 1 | 2013 | 45 | 0.020 |
Why?
|
| Hospitalization | 1 | 2023 | 2460 | 0.020 |
Why?
|
| Lung | 1 | 2021 | 4106 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 11772 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 2865 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5423 | 0.010 |
Why?
|